Febby Gunawan Siswanto

Febby Gunawan Siswanto

Auto-generated profile, based on publicly available information

Febby Gunawan Siswanto

Disease Control Research Group, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2026 in PLOS ONE
Verified
Journal Article
Open access
APAri Probandari
Ari Probandari
KMKyra Modesty
Kyra Modesty
VTVivienne Tjung
Vivienne Tjung
BSBrigitta Ellycia Sitepu
Brigitta Ellycia Sitepu
FSFebby Gunawan Siswanto
Febby Gunawan Siswanto
VWVitri Widyaningsih
Vitri Widyaningsih
Background: The coexistence of tuberculosis (TB) with other chronic diseases, such as diabetes mellitus (DM) and hypertension, presents a growing challenge for efforts to end TB due to the complex interactions of coordinated care among relevant care providers and increased risk of adverse outcomes. The comorbidities between TB and DM underscore the necessity of integrated care approaches that span screening, diagnosis, and treatment. Although integrated care models have the potential to improve patient outcomes by supporting people to complete treatment, improving retention in care, and streamlining service delivery, the understanding of low integration within existing health systems is also limited. This scoping review aims to map existing models of integrated TB, DM, and hypertension case management, identify potential benefits and examine barriers to integration, and define strategies for effective implementation. Methods: This scoping review examined original research papers on the integrated management of TB, DM, and hypertension, published from January 2005 to January 2025. Studies of various designs were included and sourced from databases such as MEDLINE, Scopus, ScienceDirect, and EMERALD using targeted search terms. Four reviewers independently screened and extracted data using a standardized form. Findings were synthesized qualitatively and discussed with experts for additional insights. Discussion: From 7,983 studies screened, 126 studies met the inclusion criteria. The findings reveal that integrated management of TB, DM, and hypertension can improve access to care, program retention, and early detection of comorbidities. Integration of services—including screening, diagnosis, treatment, counseling, and support for patients’ self-management—was generally well-received, practical to implement, and contributed to improved patient outcomes. Nevertheless, several barriers remain, such as fragmented health systems, lack of standardized protocols, inadequate provider training, limited health information systems, and insufficient financing mechanisms. Addressing these challenges requires systemic interventions, including strengthened policy and regulatory frameworks, capacity-building through structured training, robust and interoperable information systems, inter-program coordination, task-shifting strategies, and patient-centered care approaches. While the evidence highlights the potential of integrated care, gaps remain in demonstrating long-term outcomes and cost-effectiveness, underscoring the need for further research and evaluation to support the scale-up of successful models across diverse health system contexts.

29 April 2026 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
RRRachmi Fauziah Rahayu
Rachmi Fauziah Rahayu
FZFathimah Afifah Zahrah
Fathimah Afifah Zahrah
TATessa Septian Anugrah
Tessa Septian Anugrah
RYRatih Yudhani
Ratih Yudhani
YYYuyun Yueniwati
Yuyun Yueniwati
FSFebby Gunawan Siswanto
Febby Gunawan Siswanto
BACKGROUND: Diabetes mellitus induces oxidative stress, inflammation, and endothelial dysfunction, accelerating atherosclerosis development marked by elevated high-sensitivity C-reactive protein (hs-CRP) and interleukin-12 (IL-12). Diabetes often causes significant vascular changes, which can be represented by carotid tunica intima thickening and elevated renin level. Metformin, which remains as the standard therapy, has limited vascular effects. Vitamin D and magnesium exhibit vasoprotective and anti-inflammatory properties; however, their combined effects on diabetic vascular injury remain unclear. This study evaluated the effects of vitamin D and magnesium combination on serum hs-CRP, IL-12, renin, and carotid tunica intima thickness in diabetic rats.METHODS: Wistar rats were diabetic-induced by 45 mg/kg streptozotocin and 110 mg/kg nicotinamide. Following the induction, the rats were subsequently assigned to receive no treatment, metformin, or a combination of vitamin D and magnesium. Healthy rats were also included as control. Blood sample was collected after 21 days of treatment. Serum hs-CRP, IL-12, and renin were measured using enzyme-linked immunosorbent assay (ELISA), while the carotid tunica intima thickness was assessed by Doppler ultrasound.RESULTS: Diabetic rats showed significant increases hs-CRP, IL-12, renin level, and intima thickness (p<0.001) compared to control. Both metformin and combination of Vitamin D and magnesium reduced these parameters, with combination of Vitamin D and magnesium showing the greatest improvement. Carotid intima thickness in the combination of Vitamin D and magnesium group was comparable to normal controls, indicating marked vascular protection.CONCLUSION: Vitamin D and magnesium combination provided superior glycemic, anti-inflammatory, and vascular protective effects compared to metformin alone. This adjunctive strategy might have potential in preventing vascular complications in diabetes.KEYWORDS: diabetes mellitus, oxidative stress, endothelial dysfunction, hs-CRP, IL-12, atherosclerosis